Drugs / QIVc
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04074928 | Sep 2019 → Sep 2020 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QIVc | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04074928 ↗ |
| Modality | Vaccine | “a cell-based quadrivalent inactivated influenza vaccine (QIVc)” PMID 36214072 ↗ Nov 2022 |
| Route | Intramuscular | “0.5 mL intramuscular dose of QIVc” NCT04074928 ↗ |